Effectiveness and safety of topical versus oral nonsteroidal anti-inflammatory drugs: A comprehensive review

Physician and Sportsmedicine

Volumn 41, Issue 2, 2013, Pages 64-74

  Klinge, Stephen A ^a   Sawyer, Gregory A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Anti inflammatory; Nonsteroidal anti inflammatory drugs; Oral; Topical

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CELECOXIB; CREATININE; DICLOFENAC; ETOFENAMATE; FELBINAC; FLURBIPROFEN; HEMOGLOBIN; IBUPROFEN; INDOMETACIN; KETOPROFEN; LIVER ENZYME; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANKLE SPRAIN; ARTICLE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HAND OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; LOCAL SKIN REACTION; LOW BACK PAIN; META ANALYSIS (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; MUSCULOSKELETAL PAIN;

EID: 84880613834     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2013.05.2016     Document Type: Article

References (51)

1. Nepple JJ, Matava MJ. Soft tissue injections in the athlete. Sports Health. 2009;1(5):396-404.
2. Leadbetter WB. Anti-inflammatory therapy in sports injury. The role of nonsteroidal drugs and corticosteroid injection. Clin Sports Med. 1995;14(2):353-410.
3. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Med. 2010;11(4):535-549.
4. Mehallo CJ, Drezner JA, Bytomski JR. Practical Management: nonsteroidal antiinflammatory drug (NSAID) use in athletic injuries. Clin J Sport Med. 2006;16(2):170-174.
5. Wick JY. Aspirin: a history, a love story. Consult Pharm. 2012;27(5): 322-329.
6. Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem. 2007;42:3-27.
7. Pearsall AW, Kovaleski JE. Update on COX-2 inhibitors and non-selective NSAIDs: safety and patient risk. Sports Medicine Update. May/June 2007;1:2-7.
8. Silverstein FE, Graham DY, Senior JR, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double blind, placebo-controlled trial. Ann Intern Med. 1995; 123(4):241-249.
9. Mamdani, M. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ. 2004;328:1415-1416.
10. Brownstein JS, Sordo M, Kohane IS, Mandl KD. The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS One. 2007;2:e840.
11. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3-25.
12. Centers for Disease Control and Prevention. Arthritis types-Osteoarthritis overview. http://www.cdc.gov/arthritis/basics/osteoarthritis.htm. Accessed October 15, 2012.
13. Conn JM, Annest JL, Gilchrist J. Sports and recreation related injury episodes in the US population, 1997-99. Inj Prev. 2003;9(2):117-23.
14. American Academy of Orthopaedic Surgeons. Guideline on the treatment of osteoarthritis of the knee-recommendations. http://www.aaos.org/research/guidelines/OAKrecommendations.pdf. Accessed October 15th, 2012.
15. Hochberg MC, Altman RD, April KT, et al; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res. 2012;64(4):465-474.
16. Altman R, Barkin RL. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med. 2009;121(2):139-147.
17. US Food and Drug Administration. FDA 2012 Approved Drug Products List. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/UCM071436.pdf. Accessed February 12, 2013.
18. Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555-574.
19. Cevc G, Mazgareanu S, Rother M. Preclinical characterisation of NSAIDs in ultradeformable carriers or conventional topical gels. Int J Pharm. 2008;360(1-2):29-39.
20. Orudis (ketoprofen) Capsules [package insert]. Philadelphia, PA: Wyeth. 1997.
21. Tegeder I, Muth-Selbach U, Lotsch J, et al. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther. 1999;65(4):357-368.
22. Rolf C, Engstrom B, Beauchard C, Jacobs LD, Le Liboux A. Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy. Rheumatology (Oxford). 1999;38(6):564-567.
23. Dominkus M, Nicolakis M, Kotz R, Wilkinson FE, Kaiser RR, Chlud K. Comparison of tissue and plasma levels of ibuprofen after oral and topical administration. Arzneimittelforschung. 1996;46(12): 1138-1143.
24. Akermark C, Forsskåhl B. Topical indomethacin in overuse injuries in athletes. A randomized double-blind study comparing Elmetacin with oral indomethacin and placebo. Int J Sports Med. 1990;11(5): 393-396.
25. Whitefield M, O'Kane CJA, Anderson S. Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther. 2002;27:409-417.
26. Martens M. Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism. Clin Rheumatol. 1997;16:25-31.
27. Vanderstraeten G, Schuermans P. Study on the effect of etofenamate 10% cream in comparison with an oral NSAID in strains and sprains due to sports injuries. Acta Belg Med Phys. 1990;13(3):139-141.
28. Cesarone MR, Belcaro G, Pellegrini L, et al. Treatment of ankle sprain in patients with vascular diseases of the lower limbs. Minerva Cardioangiol. 2008;56(5 suppl):39-46.
29. Hosie GA. The topical NSAID, felbinac, versus oral ibuprofen: a comparison of efficacy in the treatment of acute lower back injury. Br J Clin Res. 1993;4:5-17.
30. Sandelin J, Harilainen A, Crone H, Hamberg P, Forsskåhl B, Tamelander G. Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee. A double blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol. 1997;26(4): 287-292.
31. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31(10):2002-2012.
32. Simon LS, Grierson LM, Naseer Z, Bookman AA, Zev Shainhouse J. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain. 2009;143(3):238-245.
33. Dickson DJ. A double-blind evaluation of topical piroxicam gel with oral ibuprofen in osteoarthritis of the knee. Curr Ther Res. 1991;49: 199-207.
34. Rother M, Lavins BJ, Kneer W, Lehnhardt K, Seidel EJ, Mazgareanu S. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis. 2007;66(9):1178-1183.
35. Underwood M, Ashby D, Cross P, et al. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 2008;336(7636):138-142.
36. Tiso RL, Tong-Ngork S, Fredlund KL. Oral versus topical Ibuprofen for chronic knee pain: a prospective randomized pilot study. Pain Physician. 2010;13(5):457-467.
37. Doi T, Akai M, Fujino K, Hoshino Y, Iwaya T, Sunami Y. Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial. Mod Rheumatol. 2010;20(1):24-33.
38. Zacher J, et al. Topical diclofenac versus oral ibuprofen: A double blind, randomized clinical trial to demonstrate efficacy and tolerability in patients with activated osteoarthritis of the finger joints (Heberden and/or Bouchard arthritis). Aktuelle Rheumatologie. 2001;26:7-14.
39. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for acute pain: a meta-analysis. BMC Fam Pract. 2004;5:10.
40. Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004;5:28.
41. Massey T, Derry S, Moore RA, McQuay HJ. Topical NSAIDs for acute pain in adults. Cochrane Database Syst Rev. 2010;6:CD007402.
42. Derry S, Moore RA, Rabbie R. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2012;9:CD007400.
43. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials. 1996;17:1-12.
44. Komatsu T, Sakurada T. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe. Eur J Pharm Sci. 2012;47(5):890-895.
45. UpToDate. Diclofenac (topical): drug information. www.uptodate.com. Accessed October 15, 2012.
46. Roth SH. Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety. Clin Interv Aging. 2011;6:125-131.
47. Andrianakos A, Avouac B, Bijlsma JWJ, et al. Prevention of non-steroidal anti-inflammatory drug (NSAID) induced gastropathy. Eur J Rheumatol Inflam. 1992;12:23-29.
48. Moore RA, Tramèr MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316(7128):333-338.
49. Zimmerman J, Siguencia J, Tsvang E. Upper gastrointestinal haemorrhage associated with cutaneous application of diclofenac gel. Am J Gastroenterol. 1995;90:2032-2034.
50. Lin J. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329(7461):324-330.
51. Moore RA, Gavaghan D, Tramer MR, Collins SL, McQuay HJ. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 1998;78:209-216.